Antimicrobial practice. Development of guidelines for gentamicin dosing

Journal of Antimicrobial Chemotherapy

Volumn 38, Issue 5, 1996, Pages 885-893

  Thomson, A H ^a,b   Duncan, N ^b   Silverstein, B ^b   Alcock, S ^c   Jodrell, D ^d  

^a Gardiner Institute   (United Kingdom)

^b Pharmacy Practice Unit   (United Kingdom)

^c Clinical Microbiology Department   (United Kingdom)

^d BEATSON WEST OF SCOTLAND CANCER CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; GENTAMICIN;

ADULT; ARTICLE; CLINICAL PROTOCOL; FEMALE; GRAM NEGATIVE SEPSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PROSPECTIVE STUDY; SEPTICEMIA;

EID: 0029849060     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/38.5.885     Document Type: Article

References (12)

1. Bertino, J. S., Booker, L. A., Franck, P. & Rybicki, B. (1991). Gentamicin pharmacokinetics in patients with malignancies. Antimicrobial Agents and Chemotherapy 35, 1501-3.
2. Cockcroft, D. W. & Gault, M. H. (1976). Prediction of creatinine clearance from serum creatinine. Nephron 16, 31-41.
3. Goodman Gilman, A., Goodman, L. S. & Gilman, A. (1980). Goodman and Gilman's the Pharmacological Basis of Therapeutics, 6th edn, p. 1709. Macmillan, New York.
4. Higa, G. M. & Murray, W. E. (1987). Alterations in aminoglycoside pharmacokinetics in patients with cancer. Clinical Pharmacy 6, 963-6.
5. Hustinx, W. N. M. & Hoepelman, I. M. (1993). Aminoglycoside dosage regimens. Is once a day enough? Clinical Pharmacokinetics 25, 427-32.
6. Kelman, A. W., Whiting, B. & Bryson, S. (1982). OPT: a package of computer programs for parameter optimisation in clinical pharmacokinetics. British Journal of Clinical Pharmacology 14, 247-56.
7. MacGowan, A. P. & Reeves, D. S. (1994). Serum aminoglycoside concentrations: the case for routine monitoring. Journal of Antimicrobial Chemotherapy 34, 829-37.
8. Moore, R. D., Lietman, P. S. & Smith, C. R. (1987). Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. Journal of Infectious Diseases 155, 93-9.
9. Nicolau, D. P., Freeman, C. D., Belliveau, P. P., Nightingale, C. H., Ross, J. W. & Quintiliani, R. (1995). Experience with a once-daily aminoglycoside program administered to 2,184 adult patients. Antimicrobial Agents and Chemotherapy 39, 650-5.
10. Parker, S. E. & Davey, P. G. (1995). Once daily aminoglycoside administration in Gram-negative sepsis. Pharmacoeconomics 7, 393-402.
11. Thomson, A. H., Campbell, K. C. & Kelman, A. W. (1990). Evaluation of six gentamicin nomograms using a bayesian parameter estimation program. Therapeutic Drug Monitoring 12, 258-63.
12. Working Party of the British Society for Antimicrobial Chemotherapy (1985). Antibiotic treatment of streptococcal and staphylococcal endocarditis. Lancet ii, 815-7.